Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Prepaid Assets (2016 - 2025)

Ocular Therapeutix has reported Prepaid Assets over the past 13 years, most recently at $10.9 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $10.9 million for Q4 2025, down 19.34% from a year ago — trailing twelve months through Dec 2025 was $10.9 million (down 19.34% YoY), and the annual figure for FY2025 was $10.9 million, down 19.34%.
  • Prepaid Assets for Q4 2025 was $10.9 million at Ocular Therapeutix, up from $8.0 million in the prior quarter.
  • Over the last five years, Prepaid Assets for OCUL hit a ceiling of $13.5 million in Q4 2024 and a floor of $3.3 million in Q3 2022.
  • Median Prepaid Assets over the past 5 years was $4.8 million (2021), compared with a mean of $6.6 million.
  • Biggest five-year swings in Prepaid Assets: surged 170.49% in 2024 and later tumbled 39.53% in 2025.
  • Ocular Therapeutix's Prepaid Assets stood at $4.8 million in 2021, then dropped by 15.22% to $4.0 million in 2022, then surged by 93.5% to $7.8 million in 2023, then surged by 72.66% to $13.5 million in 2024, then fell by 19.34% to $10.9 million in 2025.
  • The last three reported values for Prepaid Assets were $10.9 million (Q4 2025), $8.0 million (Q3 2025), and $8.8 million (Q2 2025) per Business Quant data.